Approval · Notice of Compliance 1879 · 1999
VARILRIX: Notice of Compliance 1879
Issued October 13, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1879
- Date
- October 13, 1999
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARILRIX | 02241047 | Marketed |
Medicinal ingredients
- VARICELLA ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN) 1,995 UNIT per 0.5ML